CVRx, Inc. (CVRX)
| Market Cap | 44.49M-80.9% |
| Revenue (ttm) | 61.19M |
| Net Income | -51.97M |
| EPS | -1.97 |
| Shares Out | 26.64M |
| PE Ratio | n/a |
| Forward PE | -0.89 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 896,556 |
| Open | 1.62 |
| Previous Close | 1.62 |
| Day's Range | 1.62 - 1.75 |
| 52-Week Range | 1.50 - 11.30 |
| Beta | 0.77 |
| Analysts | none |
| Price Target | 4.58(+174.45%) |
| Earnings Date | Nov 5, 2026 |
CVRx, Inc. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
About CVRX
CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$CVRX stock is featured in our Insider Score Rankings, Congress Trading, and Insider Trades datasets.
→ All Stock ListsCongress Trading
Recent trades of CVRX by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Richard BlumenthalSenate / D | Sale$1.00K – $15.00K | Jul 8, 2026 |
Recently reported changes in CVRX holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by CVRX's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
CVRX Estimated quarterly lobbying spending
Source: U.S. Senate LDA
CVRX Revenue by Segment or Geography
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New CVRX patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to CVRX from public contracts
Source: USAspending.gov
CVRX Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from CVRX’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score